Role of CSF serology in follow-up of subacute sclerosing panencephalitis patients on treatment

Indian J Med Microbiol. 2006 Apr;24(2):131-2. doi: 10.4103/0255-0857.25202.

Abstract

Subacute sclerosing panencephalitis (SSPE) is a progressive inflammatory disease of the central nervous system with poor prognosis and high mortality. No effective treatment has a proven role; oral isoprinosine and intrathecal administration of alpha-interferon may prolong survival. We report an unusual case of adult onset SSPE patient on treatment with significant clinical improvement, even in the absence of conversion to seronegativity in either CSF or serum, on follow-up serological examination.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • Antibodies, Viral / cerebrospinal fluid*
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use
  • Female
  • Humans
  • Inosine Pranobex / administration & dosage
  • Inosine Pranobex / therapeutic use
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use
  • Measles / complications
  • Measles virus / immunology*
  • Subacute Sclerosing Panencephalitis / blood
  • Subacute Sclerosing Panencephalitis / cerebrospinal fluid*
  • Subacute Sclerosing Panencephalitis / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Viral
  • Antiviral Agents
  • Interferon-alpha
  • Inosine Pranobex